217730 — Kang Stem Biotech Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Kang Stem Biotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-26,394	-19,746	-21,827	-20,176	-23,221
Depreciation
Amortisation
Non-Cash Items	4,741	938	453	695	1,097
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	6,235	1,820	506	-3,254	1,711
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-13,322	-13,994	-16,994	-18,864	-16,498
Capital Expenditures	-17,065	-3,054	-4,650	-847	-1,409
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-21,065	32,903	-20,125	17,083	-895
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-38,131	29,849	-24,775	16,236	-2,304
Financing Cash Flow Items	2.27	-452	-0.005	-61.2	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	55,911	-13,567	39,286	-231	19,977
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4,459	2,288	-2,427	-2,861	1,175